Document Detail


The morbidly adherent placenta: an overview of management options.
MedLine Citation:
PMID:  20804337     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Abstract Morbidly adherent placenta is often associated with severe maternal morbidity. An increased incidence over the recent years may be secondary to the increased cesarean section rates. Identification of patients with risk factors antenatally is essential for the early diagnosis and management. Diagnosis can be achieved by ultrasound or MRI in the majority of cases. Management aims to ensure a safe delivery of the fetus, alongside measures of prevention or effective management of postpartum hemorrhage. When a hysterectomy is performed, a multidisciplinary team with surgical expertise and facilities for transfusion and further interventions including arterial ligation and interventional radiology should be available. The options for conservative treatments offer the potential to preserve fertility but further research with prospective evaluation of the different approaches is necessary.
Authors:
Stergios K Doumouchtsis; Sabaratnam Arulkumaran
Related Documents :
8677307 - Intussusception. issues and controversies related to diagnosis and reduction.
525757 - Snake bite in australia--the problems involved and a protocol for hospital management.
7396077 - The carotid "string" sign. differential diagnosis and management.
6026727 - The management of acute leukemia.
18560337 - Antidiabetic components contained in vegetables and legumes.
17022917 - The ottawa hospital's clinical practice guideline for the second stage of labour.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Acta obstetricia et gynecologica Scandinavica     Volume:  89     ISSN:  1600-0412     ISO Abbreviation:  Acta Obstet Gynecol Scand     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-31     Completed Date:  2010-09-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370343     Medline TA:  Acta Obstet Gynecol Scand     Country:  England    
Other Details:
Languages:  eng     Pagination:  1126-33     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynaecology, St. George's University of London, UK. sdoum@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Balloon Dilatation
Blood Loss, Surgical
Blood Transfusion
Cesarean Section
Embolization, Therapeutic
Female
Fertility
Folic Acid Antagonists / therapeutic use
Humans
Hysterectomy
Magnetic Resonance Imaging
Methotrexate / therapeutic use
Myometrium / pathology
Placenta / blood supply,  pathology,  surgery
Placenta Accreta / diagnosis,  epidemiology,  etiology,  therapy*
Placenta Previa / therapy
Postoperative Care
Postpartum Hemorrhage / etiology,  therapy
Pregnancy
Prenatal Care
Preoperative Care
Risk Factors
Ultrasonography, Doppler
Ultrasonography, Prenatal
Urinary Bladder Diseases / etiology,  surgery
Chemical
Reg. No./Substance:
0/Folic Acid Antagonists; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biology of pregnancy-associated plasma protein-A in relation to prenatal diagnostics: an overview.
Next Document:  Validity of self-reported birthweight among middle-aged and elderly women in the Danish Nurse Cohort...